<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38578638</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Common Seasonal Pathogens and Epidemiology of Henoch-Schönlein Purpura Among Children.</ArticleTitle><Pagination><StartPage>e245362</StartPage><MedlinePgn>e245362</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e245362</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2024.5362</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Henoch-Schönlein purpura (HSP) is the most common type of vasculitis in children. The factors that trigger the disease are poorly understood. Although several viruses and seasonal bacterial infections have been associated with HSP, differentiating the specific associations of these pathogens with the onset of HSP remains a challenge due to their overlapping seasonal patterns.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To analyze the role of seasonal pathogens in the epidemiology of HSP.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This cohort study comprised an interrupted time-series analysis of patient records from a comprehensive national hospital-based surveillance system. Children younger than 18 years hospitalized for HSP in France between January 1, 2015, and March 31, 2023, were included.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="UNASSIGNED">Implementation and relaxation of nonpharmaceutical interventions (NPIs) for the COVID-19 pandemic, such as social distancing and mask wearing.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">The main outcomes were the monthly incidence of HSP per 100 000 children, analyzed via a quasi-Poisson regression model, and the estimated percentage of HSP incidence potentially associated with 14 selected common seasonal pathogens over the same period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study included 9790 children with HSP (median age, 5 years [IQR, 4-8 years]; 5538 boys [56.4%]) and 757 110 children with the infectious diseases included in the study (median age, 0.7 years [IQR, 0.2-2 years]; 393 697 boys [52.0%]). The incidence of HSP decreased significantly after implementation of NPIs in March 2020 (-53.6%; 95% CI, -66.6% to -40.6%; P &lt; .001) and increased significantly after the relaxation of NPIs in April 2021 (37.2%; 95% CI, 28.0%-46.3%; P &lt; .001). The percentage of HSP incidence potentially associated with Streptococcus pneumoniae was 37.3% (95% CI, 22.3%-52.3%; P &lt; .001), the percentage of cases associated with Streptococcus pyogenes was 25.6% (95% CI, 16.7%-34.4%; P &lt; .001), and the percentage of cases associated with human rhino enterovirus was 17.1% (95% CI, 3.8%-30.4%; P = .01). Three sensitivity analyses found similar results.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">This study found that significant changes in the incidence of HSP simultaneously with major shifts in circulating pathogens after NPIs for the COVID-19 pandemic indicated that approximately 60% of HSP incidence was potentially associated with pneumococcus and group A streptococcus. This finding suggests that preventive measures against these pathogens could reduce the incidence of pediatric HSP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Felix</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Competence Centre RAISE Antilles-Guyane, EpiCliV Research Unit, Department of General Pediatrics, Martinique University Hospital, University of French West Indies, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assad</LastName><ForeName>Zein</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection, Antimicrobials, Modeling, Evolution, Paris Cité University, INSERM UMR 1137, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bidet</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infection, Antimicrobials, Modeling, Evolution, Paris Cité University, INSERM UMR 1137, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caseris</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumaine</LastName><ForeName>Cécile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faye</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Cité, INSERM UMR-1123, ECEVE, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melki</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics, Rheumatology and Pediatric Internal Medicine, Children's Hospital, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaguelidou</LastName><ForeName>Florentia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center of Clinical Investigations, INSERM CIC1426, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valtuille</LastName><ForeName>Zaba</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center of Clinical Investigations, INSERM CIC1426, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouldali</LastName><ForeName>Naïm</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection, Antimicrobials, Modeling, Evolution, Paris Cité University, INSERM UMR 1137, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meinzer</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Department of General Pediatrics, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche sur l'inflammation UMR 1149, Université Paris Cité, INSERM, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011695" MajorTopicYN="Y">IgA Vasculitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Ouldali reported receiving grants from Pfizer, GSK, Sanofi, and MSD outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38578638</ArticleId><ArticleId IdType="pmc">PMC10998156</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.5362</ArticleId><ArticleId IdType="pii">2817207</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197-1202. doi:10.1016/S0140-6736(02)11279-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)11279-7</ArticleId><ArticleId IdType="pubmed">12401245</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaishvili M, Pazhava A, Di Lernia V. Viral infections may be associated with Henoch-Schönlein purpura. J Clin Med. 2023;12(2):697. doi:10.3390/jcm12020697</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020697</ArticleId><ArticleId IdType="pmc">PMC9862009</ArticleId><ArticleId IdType="pubmed">36675626</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li S, Dong L, Feng S, Wang Z. Parainfluenza infection is associated with Henoch-Schönlein purpura in children. Pediatr Infect Dis. 2016;8(4):110-114. doi:10.1016/j.pid.2016.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pid.2016.06.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Danino D, Ben-Shimol S, van der Beek BA, et al. . Decline in pneumococcal disease in young children during the coronavirus disease 2019 (COVID-19) pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study. Clin Infect Dis. 2022;75(1):e1154-e1164. doi:10.1093/cid/ciab1014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab1014</ArticleId><ArticleId IdType="pmc">PMC8754767</ArticleId><ArticleId IdType="pubmed">34904635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh DK, Foley DA, Minney-Smith CA, et al. . Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis. 2021;72(12):2199-2202. doi:10.1093/cid/ciaa1475</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1475</ArticleId><ArticleId IdType="pmc">PMC7543326</ArticleId><ArticleId IdType="pubmed">32986804</ArticleId></ArticleIdList></Reference><Reference><Citation>Angoulvant F, Ouldali N, Yang DD, et al. . Coronavirus disease 2019 pandemic: impact caused by school closure and national lockdown on pediatric visits and admissions for viral and nonviral infections—a time series analysis. Clin Infect Dis. 2021;72(2):319-322. doi:10.1093/cid/ciaa710</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa710</ArticleId><ArticleId IdType="pmc">PMC7314162</ArticleId><ArticleId IdType="pubmed">33501967</ArticleId></ArticleIdList></Reference><Reference><Citation>Maison N, Peck A, Illi S, et al. . The rising of old foes: impact of lockdown periods on “non–SARS-CoV-2” viral respiratory and gastrointestinal infections. Infection. 2022;50(2):519-524. doi:10.1007/s15010-022-01756-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01756-4</ArticleId><ArticleId IdType="pmc">PMC8787179</ArticleId><ArticleId IdType="pubmed">35076891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N, Deceuninck G, Lefebvre B, et al. . Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis. Lancet Reg Health Am. 2023;19:100448. doi:10.1016/j.lana.2023.100448</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2023.100448</ArticleId><ArticleId IdType="pmc">PMC9958468</ArticleId><ArticleId IdType="pubmed">36852331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassoued Y, Assad Z, Ouldali N, et al. . Unexpected increase in invasive group A streptococcal infections in children following respiratory viruses outbreak in France: a 15-year time-series analysis. Open Forum Infect Dis. 2023;10(5):ofad188. doi:10.1093/ofid/ofad188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad188</ArticleId><ArticleId IdType="pmc">PMC10167988</ArticleId><ArticleId IdType="pubmed">37180594</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Valtuille Z, Lefevre-Utile A, Ouldali N, et al. . Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysis. EClinicalMedicine. 2023;61:102078. doi:10.1016/j.eclinm.2023.102078</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102078</ArticleId><ArticleId IdType="pmc">PMC10359724</ArticleId><ArticleId IdType="pubmed">37483549</ArticleId></ArticleIdList></Reference><Reference><Citation>Österback R, Tevaluoto T, Ylinen T, et al. . Simultaneous detection and differentiation of human rhino- and enteroviruses in clinical specimens by real-time PCR with locked nucleic acid probes. J Clin Microbiol. 2013;51(12):3960-3967. doi:10.1128/JCM.01646-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01646-13</ArticleId><ArticleId IdType="pmc">PMC3838063</ArticleId><ArticleId IdType="pubmed">24048533</ArticleId></ArticleIdList></Reference><Reference><Citation>Population et structure de la population: résultats par sexe et âge. Institut National de la Statistique et des Études Économiques . January 26, 2024. Accessed December 15, 2022. https://www.insee.fr/fr/statistiques/series/103088458</Citation></Reference><Reference><Citation>Assad Z, Valtuille Z, Rybak A, et al. . Unique changes in the incidence of acute chest syndrome in children with sickle-cell disease unravel the role of respiratory pathogens: a time-series analysis. Chest. 2024;165(1):150-160. doi:10.1016/j.chest.2023.07.4219</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2023.07.4219</ArticleId><ArticleId IdType="pubmed">37544426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafay C, Assad Z, Ouldali N, et al. . Increased incidence of pediatric uveitis associated with the COVID-19 pandemic occurring before COVID-19 vaccine implementation: a time-series analysis. J Pediatr. Published online August 21, 2023. doi:10.1016/j.jpeds.2023.113682</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2023.113682</ArticleId><ArticleId IdType="pubmed">37611738</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley S, Ali MS, Berencsi K, Judge A, Prieto-Alhambra D. Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study. Clin Epidemiol. 2019;11:197-205. doi:10.2147/CLEP.S176723</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S176723</ArticleId><ArticleId IdType="pmc">PMC6394245</ArticleId><ArticleId IdType="pubmed">30881136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309. doi:10.1046/j.1365-2710.2002.00430.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2710.2002.00430.x</ArticleId><ArticleId IdType="pubmed">12174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheysson F, Vibet MA, Guillemot D, Watier L. Estimation of exposure-attributable fractions from time series: a simulation study. Stat Med. 2018;37(24):3437-3454. doi:10.1002/sim.7818</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7818</ArticleId><ArticleId IdType="pubmed">29938833</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc. 1992;87(417):178-183. doi:10.1080/01621459.1992.10475190</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1992.10475190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases. Medicine (Baltimore). 2018;97(36):e12217. doi:10.1097/MD.0000000000012217</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000012217</ArticleId><ArticleId IdType="pmc">PMC6133644</ArticleId><ArticleId IdType="pubmed">30200139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YH, Hung CF, Hsu CR, et al. . A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan. Rheumatology (Oxford). 2005;44(5):618-622. doi:10.1093/rheumatology/keh544</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keh544</ArticleId><ArticleId IdType="pubmed">15671050</ArticleId></ArticleIdList></Reference><Reference><Citation>Oni L, Sampath S. Childhood IgA vasculitis (Henoch Schönlein purpura)—advances and knowledge gaps. Front Pediatr. 2019;7:257. doi:10.3389/fped.2019.00257</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00257</ArticleId><ArticleId IdType="pmc">PMC6610473</ArticleId><ArticleId IdType="pubmed">31316952</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Li Y, Wu X. IgA vasculitis update: epidemiology, pathogenesis, and biomarkers. Front Immunol. 2022;13:921864. doi:10.3389/fimmu.2022.921864</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.921864</ArticleId><ArticleId IdType="pmc">PMC9574357</ArticleId><ArticleId IdType="pubmed">36263029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JJ, Xu Y, Liu FF, et al. . Association of the infectious triggers with childhood Henoch-Schönlein purpura in Anhui Province, China. J Infect Public Health. 2020;13(1):110-117. doi:10.1016/j.jiph.2019.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2019.07.004</ArticleId><ArticleId IdType="pubmed">31337540</ArticleId></ArticleIdList></Reference><Reference><Citation>Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA. Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore). 2001;80(5):279-290. doi:10.1097/00005792-200109000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-200109000-00001</ArticleId><ArticleId IdType="pubmed">11552081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shak JR, Vidal JE, Klugman KP. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol. 2013;21(3):129-135. doi:10.1016/j.tim.2012.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2012.11.005</ArticleId><ArticleId IdType="pmc">PMC3729046</ArticleId><ArticleId IdType="pubmed">23273566</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R, Bidet P, Varon E, et al. . Unprecedentedly high rates of group A Streptococcus nasopharyngeal carriage in infants and toddlers in France, 2022-2023. Infect Dis Now. 2023;53(5):104720. doi:10.1016/j.idnow.2023.104720</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104720</ArticleId><ArticleId IdType="pubmed">37196808</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss PF, Klink AJ, Luan X, Feudtner C. Temporal association of Streptococcus, Staphylococcus, and parainfluenza pediatric hospitalizations and hospitalized cases of Henoch-Schönlein purpura. J Rheumatol. 2010;37(12):2587-2594. doi:10.3899/jrheum.100364</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.100364</ArticleId><ArticleId IdType="pubmed">20843903</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan GZ, Li RX, Jiang Q, et al. . Streptococcal infection in childhood Henoch-Schönlein purpura: a 5-year retrospective study from a single tertiary medical center in China, 2015-2019. Pediatr Rheumatol Online J. 2021;19(1):79. doi:10.1186/s12969-021-00569-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00569-3</ArticleId><ArticleId IdType="pmc">PMC8173722</ArticleId><ArticleId IdType="pubmed">34078391</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdoch DR, O’Brien KL, Driscoll AJ, Karron RA, Bhat N; Pneumonia Methods Working Group; PERCH Core Team . Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis. 2012;54(suppl 2):S146-S152. doi:10.1093/cid/cir1073</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir1073</ArticleId><ArticleId IdType="pubmed">22403229</ArticleId></ArticleIdList></Reference><Reference><Citation>Boix-Palop L, Fernández T, Pelegrín I, et al. . Delayed cerebral vasculopathy in pneumococcal meningitis: epidemiology and clinical outcome: a cohort study. Int J Infect Dis. 2020;97:283-289. doi:10.1016/j.ijid.2020.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.005</ArticleId><ArticleId IdType="pubmed">32531430</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt R, Carlsson F, Mörgelin M, Tati R, Lindahl G, Karpman D. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schönlein purpura. Am J Pathol. 2010;176(2):608-618. doi:10.2353/ajpath.2010.090428</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090428</ArticleId><ArticleId IdType="pmc">PMC2808069</ArticleId><ArticleId IdType="pubmed">20056836</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda M, Nakanishi K, Yoshizawa N, Iijima K, Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis. 2003;41(2):366-370. doi:10.1053/ajkd.2003.50045</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2003.50045</ArticleId><ArticleId IdType="pubmed">12552498</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigante D, Castellazzi L, Bosco A, Esposito S. Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura? Autoimmun Rev. 2013;12(10):1016-1021. doi:10.1016/j.autrev.2013.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.04.003</ArticleId><ArticleId IdType="pubmed">23684700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>